Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
MAb362
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/21/2020
Ad5-S-nb2
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/21/2020
Birinapant
Potential treatment - theoretical effect Experimental Antiviral Aug/20/2020
Dynasore
Potential treatment - theoretical effect Experimental Antiviral Aug/20/2020
Autologous conditioned serum
Potential treatment - clinical evidence Experimental Other treatment Aug/20/2020
Galangin
Potential treatment - theoretical effect Natural product Antiviral Aug/18/2020
Sesamin
Potential treatment - theoretical effect Natural product Antiviral Aug/18/2020
Vitamin B12
Potential treatment - clinical evidence Natural product Other treatment Aug/18/2020
Lumacaftor
Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/17/2020
RQ3013-VLP
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/17/2020
89C8-ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/17/2020
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate
Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]oxane-3,4,5-triol
Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020
Noricaritin
Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020
Ad5-nCoV
Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020
WIV04 strain vaccine
Potential treatment - clinical evidence Experimental Vaccine Aug/13/2020
Hanshiyi Formula
Potential treatment - clinical evidence Natural product Unknown Aug/13/2020
Artesunate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/13/2020
BNT162b1
Potential treatment - clinical evidence Experimental Vaccine Aug/12/2020
2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Aug/12/2020